PharmaCCX, Inc. — Form D
PharmaCCX, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-03-19. The offering totals $7.0M, of which $3.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2020-03-19
- Form: D
- Accession: 0001759780-20-000003
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $3.0M
- Remaining: $4.0M
- Investors: 4
- Date of first sale: 2020-03-06
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-363260
Issuer
- Name: PharmaCCX, Inc.
- CIK: 0001759780
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 867 Boylston Street, Boston, MA, 02116
- Phone: 508-658-9080
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Armen Shankar Solakhyan | Executive Officer | Boston, MA |
| Peter Rice | Executive Officer | Boston, MA |
| Nathan Sigworth | Director | Boston, MA |
| Nathan Sigworth | Executive Officer | Boston, MA |
| Julia Shankar Bernstein | Director | Boston, MA |
| Rob Shankar Kniaz | Director | Boston, MA |
| Barath Shankar Subramanian | Director | Boston, MA |
Other filings by this issuer (2)
More